CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? 中国肺高血压诊断和治疗指南2018 Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes
|<< 1 2 3 4 5 6 7 8 >>|

GuidelineEuropean Heart Journal (2022) 00, 1–114

JOURNAL：Eur J Heart. Article Link

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

ESC/ERS Scientific Document Groupnt of pulmonary hypertension Keywords: PH; PAH; guideline

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top